about
Qualitative analysis of Adenomatous Polyposis Coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker.Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.Probable Chemical Hypoxia Effects on Progress of CNV Through Induction of Promoter CpG Demethylation and Overexpression of IL17RC in Human RPE Cells.The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer.Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications.Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cellsPunicic acid: A potential compound of pomegranate seed oil in Type 2 diabetes mellitus managementHypermethylation of IL-10 gene is responsible for its low mRNA expression in Behçet's diseaseDown-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAILSimultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapyCalcitonin administration improves endometrial receptivity via regulation of LIF, Muc-1 and microRNA Let-7a in miceDownregulation of HDAC2 and HDAC3 via oleuropein as a potent prevention and therapeutic agent in MCF-7 breast cancer cellsThe crucial role of ZEB2: From development to epithelial-to-mesenchymal transition and cancer complexityGene expression of TWIST1 and ZBTB16 is regulated by methylation modifications during the osteoblastic differentiation of mesenchymal stem cellsThe hopeful anticancer role of oleuropein in breast cancer through histone deacetylase modulationmicroRNAs involved in T-cell development, selection, activation, and hemostasis
P50
Q30857110-5041AB5C-7133-4C0B-9274-1B70B3CB6771Q36294979-88936849-1B83-40A3-8E04-F19986D9A307Q38924650-C5DA6E72-1FCA-451F-A479-4C35AECADB0CQ47735651-A9680081-B014-4CCC-BC45-D1C4CF15FFF9Q48197662-EBFA1FEF-86D8-433C-A79D-C851E701675CQ48297890-3D2B385E-B8F2-4BC7-884C-46B9D8902EAFQ57467088-85C54254-C06D-4FBA-B076-AEBB88462B89Q57467123-9EB45EBB-C8FB-4FC3-A654-4B8D2F421090Q88543584-AB410BBD-4F36-442B-8DC5-5BFDEFF1F0A3Q88613973-D8AFEC09-A737-4C54-971E-04B53DE75380Q89111204-2A05D55F-1C33-448F-A39F-EA0E1D7F083CQ90402529-86899803-5E85-4D62-A9DD-959ABF2B2A9FQ90933472-7B517ABD-BE65-403B-9D52-AC66A2158EDDQ91657925-5051B930-5412-4251-AE0B-BA8E41D921F7Q91673707-2AC3C113-4AE2-40F3-AB7D-2D252BF80239Q92234343-7BFCCAE8-0C59-4A2E-ABDE-FD302B4EBA35Q93176663-DFF032CF-54D7-4836-9226-2F2CAEC6837B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Mohammad Reza Alivand
@en
Mohammad Reza Alivand
@nl
type
label
Mohammad Reza Alivand
@en
Mohammad Reza Alivand
@nl
prefLabel
Mohammad Reza Alivand
@en
Mohammad Reza Alivand
@nl
P31
P496
0000-0002-5847-3594